Cymbiotika
4 known investors
Cymbiotika is a direct-to-consumer supplement brand that makes liposomal-delivery nutritional products, such as magnesium and glutathione, formulated with pharmaceutical-grade ingredients and backed by independent clinical trials. It sells supplements to consumers through a subscription and e-commerce model.
ConsumerDirect to ConsumerWellness & Fitness
Investors · 4
Also in the syndicate · 3
Alix EarleHailey BieberKendall Jenner
Funding
SEC filings, press & company announcements$25M disclosed across 1 of 2 rounds · 2025–2026
- $25MraisedAug 2026 · 2 sources
Alix Earle, Hailey Bieber, Kendall Jenner
Source ↗ - Undisclosed amountSeed RoundDec 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Cymbiotika do?
- Cymbiotika is a direct-to-consumer supplement brand that makes liposomal-delivery nutritional products, such as magnesium and glutathione, formulated with pharmaceutical-grade ingredients and backed by independent clinical trials. It sells supplements to consumers through a subscription and e-commerce model.
- Who are Cymbiotika's investors?
- Cymbiotika's investors include AOKI LABS.
- How much funding has Cymbiotika raised?
- Cymbiotika has disclosed $25M raised across 1 of its 2 known rounds.